Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TGTX

TG Therapeutics Inc

Jun 08 • 04:00PM ET

40.95

+0.79 1.97 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: INCY BMRN ACAD AXSM MDGL KRYS PTGX RYTM VKTX NBIX

| Held by: IJR VTI IWM XBI VB VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	14.27	EPS (ttm)	2.87	Insider Own	7.16%	Shs Outstand	153.09M	Perf Week	9.46%
Market Cap	6.27B	Forward P/E	16.17	EPS next Y	2.53	Insider Trans	0.00%	Shs Float	142.12M	Perf Month	-4.82%
Enterprise Value	6.51B	PEG	4.52	EPS next Q	0.36	Inst Own	69.14%	Short Float	19.78%	Perf Quarter	40.29%
Income	461.90M	P/S	8.95	EPS this Y	-50.18%	Inst Trans	0.84%	Short Ratio	13.59	Perf Half Y	30.50%
Sales	700.35M	P/B	10.75	EPS next Y	83.51%	ROA	42.27%	Short Interest	28.11M	Perf YTD	37.37%
Book/sh	3.81	P/C	12.19	EPS next 5Y	3.58%	ROE	112.60%	52W High	44.65 -8.29%	Perf Year	2.22%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	34.60%	52W Low	25.28 61.99%	Perf 3Y	41.30%
Dividend Est.	-	EV/EBITDA	43.08	Sales past 3/5Y	504.86% 426.73%	Gross Margin	83.05%	Volatility	4.87% 3.89%	Perf 5Y	10.20%
Dividend TTM	-	EV/Sales	9.29	EPS Y/Y TTM	1079.73%	Oper. Margin	21.35%	ATR (14)	1.70	Perf 10Y	433.20%
Dividend Ex-Date	-	Quick Ratio	5.12	Sales Y/Y TTM	81.26%	Profit Margin	65.95%	RSI (14)	59.79	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	5.81	EPS Q/Q	297.43%	SMA20	2.77%	Beta	1.65	Target Price	48.00
Payout	0.00%	Debt/Eq	1.29	Sales Q/Q	69.56%	SMA50	10.16%	Rel Volume	0.75	Prev Close	40.16
Employees	399	LT Debt/Eq	1.29	Earnings	May 06 BMO	SMA200	24.69%	Avg Volume	2.07M	Price	40.95
IPO	Dec 14, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-56.44% 2.29%	Trades		Volume	1,555,890	Change	1.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)